���ϴ��¼�

(object) array( 'id' => '5178801', 'url' => 'FR/treatment-naive_₁', 'image' => '', 'title' => 'Patient naïf de traitement', 'tags' => array ( 0 => 'Patient naïf de traitement', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => 'Tylenol', 4 => '', ), 'term' => 'Patient naïf de traitement', 'source_id' => 3284753, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'product' => array ( 0 => 'Tylenol', ), 'lastedit' => '20150721112814', 'part_of_speech' => 'adjective', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => '\'Patient naïf de traitement\' ou \'Patient naïf de médicaments\' se réfère à quelqu\'un n\'ayant encore jamais pris de traitement contre le VIH. Quelqu\'un qui prend déjà des médicaments est appelé \'patient déjà sous traitement\'.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507305079942676480, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Term' => 'treatment-naive', 'Definition' => '‘Treatment-naive’ or ‘drug naive’ refers to someone who has never used HIV drugs. Someone who has used drugs before is called ‘treatment-experienced’.', 'Part of Speech' => 'adjective', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Product' => 'Tylenol', 'Creation User' => 'Chiara conte', 'Creation Date' => '2012/6/29', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'treatment-naive_₁', )

(object) array( 'id' => '3951142', 'url' => 'FR/Yawning-No-More', 'image' => 'yawning.jpg; bush yawning.jpg;', 'title' => 'Yawning-No-More', 'tags' => array ( 0 => 'Yawning-No-More', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'Yawning-No-More', 'source_id' => 639288, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20150721084108', 'part_of_speech' => 'proper noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un nouveau médicament de relaxation musculaire qui stoppe les bâillements pendant un certain nombre d\'heures. Le bâillement est une réaction allergique du corps à cause de la fatigue, du manque de stimulation, ou de l\'ennui. Yawning-No-More détend les muscles qui induisent le bâillement ainsi la personne peut éviter de bâiller jusqu\'à cinq heures. Le bâillement peut être gênant lors de rassemblements sociaux ou des réunions d\'affaires car il peut montrer un manque d\'intérêt ou d\'énergie. Ce nouveau médicament promet de changer sensiblement la façon dont la société voit le bâillement.', 'usage_comment' => '', 'glossary' => '', 'width' => 503, 'height' => 340, '_version_' => 1507294573051772928, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Term' => 'Yawning-No-More', 'Definition' => 'A new muscle relaxation drug that stops yawning for a number of hours. Yawing is an allergic reaction of the body due to tiredness, lack of stimulation, or boredom. Yawning-No-More relaxes the muscles that induce yawning so the person can be spared of yawning for up to five hours. Yawning can be embarrassing during social gatherings or business meetings as it may show a lack of interests or energy. This new drug promises to substantially change the way society views yawning.', 'Part of Speech' => 'proper noun', 'Usage Status' => 'New', 'Sample Image' => 'yawning.jpg; bush yawning.jpg;', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'BruceLH', 'Creation Date' => '2011/1/23', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Yawning-No-More', )

(object) array( 'id' => '6227764', 'url' => 'FR/sponsor_investigator', 'image' => '', 'title' => 'Sponsor-investigateur', 'tags' => array ( 0 => 'Sponsor-investigateur', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Sponsor-investigateur', 'source_id' => 4010894, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105912', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'La personne qui initie et conduit l\'étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851745107968, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Company' => 'National Library of Medicine', 'Definition' => 'The person who both initiates and conducts the clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'sponsor investigator', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'sponsor_investigator', )

(object) array( 'id' => '10479591', 'url' => 'FR/actinic_keratoses_₂', 'image' => '', 'title' => 'Kératose actinique', 'tags' => array ( 0 => 'Kératose actinique', 1 => 'Beauty', 2 => 'Skin care', 3 => '', ), 'term' => 'Kératose actinique', 'source_id' => 5092398, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Beauty', ), 'category' => array ( 0 => 'Skin care', ), 'lastedit' => '20150728083418', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Lésions précancéreuses se traduisant par une zone rouge, épaisse et rugueuse ; elles apparaissent habituellement sur une peau endommagée par le soleil.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507928310838984706, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Definition' => 'Precancerous growths that can appear red, thick, and rough; usually found on sun-damaged skin.', 'Part of Speech' => 'noun', 'Industry' => 'Beauty', 'Product Category' => 'Skin care', 'Creation User' => 'MaryK', 'Creation Date' => '2013/3/15', 'Term' => 'actinic keratoses', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'actinic_keratoses_₂', )

(object) array( 'id' => '6227397', 'url' => 'FR/exclusion_criteria_₁', 'image' => '', 'title' => 'Critères d\'exclusion', 'tags' => array ( 0 => 'Critères d\'exclusion', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Critères d\'exclusion', 'source_id' => 4010892, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105910', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Les facteurs ou les raisons qui empêchent une personne de participer à une étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851744059394, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Company' => 'National Library of Medicine', 'Definition' => 'The factors or reasons that prevent a person from participating in a clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'exclusion criteria', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'exclusion_criteria_₁', )

(object) array( 'id' => '2315639', 'url' => 'FR/spirulina_₁', 'image' => 'espirulina-3.jpg', 'title' => 'Spiruline', 'tags' => array ( 0 => 'Spiruline', 1 => 'Pharmaceutical', 2 => 'Healthcare supplement', 3 => '', ), 'term' => 'Spiruline', 'source_id' => 1658962, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Healthcare supplement', ), 'lastedit' => '20150721112809', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'La spiruline est une bactérie bleu-vert du groupe des cyanobactéries ayant une forte valeur nutritionnelle : elle contient des protéines et de la vitamine B12. Les compléments alimentaires sont composés de deux espèces de spiruline : Arthrospira platensis et Arthrospira maxima. Elle est devenue populaire en tant que complément alimentaire à la fin du XXe siècle.', 'usage_comment' => '', 'glossary' => '', 'width' => 250, 'height' => 280, '_version_' => 1507305079939530752, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Term' => 'spirulina', 'Definition' => 'Spirulina is a green-blue bacterium of the Cyanobacteria group of a high nutritional value: it contains proteins and B12 vitamin. The nutritional supplements are made of two species of spirulina: Arthrospira platensis and Arthrospira maxima. It became popular as a nutritional supplement at the end of the XX century.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Healthcare supplement', 'Creation User' => 'esb', 'Creation Date' => '2011/10/6', 'Sample Image' => 'espirulina-3.jpg', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'spirulina_₁', )

(object) array( 'id' => '3951178', 'url' => 'FR/superbug', 'image' => 'Superbug.jpg;', 'title' => '���ܱ�����������é�������', 'tags' => array ( 0 => '���ܱ�����������é�������', 1 => 'Pharmaceutical', 2 => '', ), 'term' => '���ܱ�����������é�������', 'source_id' => 275134, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20150721084102', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Bactéries résistantes à presque tous les antibiotiques. Les gènes peuvent être transférés entre les bactéries par conjugaison, transduction ou transformation. Cela signifie que les gènes de résistance aux antibiotiques peuvent se lier à de nombreux types de germes courants et leur confèrent une importante résistance aux médicaments, en créant de superbactéries dangereuses. La dernière épidémie de superbactéries implique des patients qui ont voyagé en Inde où il y a une surpopulation et un usage excessif établi des antibiotiques. Beaucoup de gens en Inde manquent également d\'eau potable et ont des diarrhées répandues ; ce sont des conditions idéales pour la création de superbactéries.', 'usage_comment' => '', 'glossary' => '', 'width' => 450, 'height' => 362, '_version_' => 1507294573051772929, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Term' => 'superbug', 'Definition' => 'Bacteria resistant to nearly all antibiotics. Genes can be transferred between bacteria by conjugation, transduction, or transformation. This means antibiotic resistance genes can hitch onto many types of common germs and confers broad drug resistance, creating dangerous superbugs. The latest outbreak of superbugs involve patients who have travel to India with an overpopulation and documented overuses antibiotics. Many people in India also lack clean water and have widespread diarrhea disease, which are ideal conditions for the creation of the superbug', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Synonym' => 'super bacteria_₀; super bug_₀', 'Sample Image' => 'Superbug.jpg;', 'Industry' => 'Pharmaceutical', 'Domain' => 'Documentation; Marketing', 'Other Reference' => 'TIN', 'Creation User' => 'Bethsm', 'Creation Date' => '2010/9/14', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'superbug', )

(object) array( 'id' => '8442002', 'url' => 'FR/thiomersal', 'image' => 'Vaccines with thiomersal.jpg;', 'title' => 'Thiomersal', 'tags' => array ( 0 => 'Thiomersal', 1 => 'Pharmaceutical', 2 => 'Vaccines', 3 => '', ), 'term' => 'Thiomersal', 'source_id' => 274263, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'lastedit' => '20150721084102', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Le thimérosal est un conservateur contenant du mercure qui est souvent utilisé dans les vaccins en raison de ses propriétés antiseptiques et antifongiques. L\'utilisation du thimérosal comme conservateur de vaccin a été controversée au cours des dernières années en raison du risque potentiellement accru de provoquer l\'autisme chez les enfants. Cependant, la dernière étude du CDC a toutefois montré qu\'aucun lien n\'avait été trouvé entre le thimérosal et l\'autisme.', 'usage_comment' => '', 'glossary' => '', 'width' => 485, 'height' => 385, '_version_' => 1507294573052821508, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Term' => 'thiomersal', 'Definition' => 'Thimerosal is a mercury-based preservative that is often used in vaccines because of its antiseptic and antifungal properties. The use of thimerosal as a vaccine preservative has been controversial in recent years due to potentially increased risk of causing children\'s autism. However, the latest CDC study however showed no link found between thimerosal and autism', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Synonym' => '', 'Sample Image' => 'Vaccines with thiomersal.jpg;', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Vaccines', 'Domain' => 'Documentation; Marketing', 'Other Reference' => 'TIN', 'Creation User' => 'Williamb', 'Creation Date' => '2010/9/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thiomersal', )

(object) array( 'id' => '6229090', 'url' => 'FR/comparison_group_₂', 'image' => '', 'title' => 'Groupe de comparaison', 'tags' => array ( 0 => 'Groupe de comparaison', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Groupe de comparaison', 'source_id' => 4011326, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104707', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un groupe de participants à une étude clinique qui est utilisé pour synthétiser les données recueillies lors de l\'étude. Ce groupe peut être identique ou différent d\'un bras de l\'étude.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081754431488, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Company' => 'National Library of Medicine', 'Definition' => 'A grouping of participants in a clinical study that is used in summarizing the data collected during the study. This grouping may be the same as or different from a study arm.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Synonym' => 'reporting_group', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'comparison group', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'comparison_group_₂', )

(object) array( 'id' => '3897820', 'url' => 'FR/variable-interval_₁', 'image' => '', 'title' => 'Intervalle variable', 'tags' => array ( 0 => 'Intervalle variable', 1 => 'Pharmaceutical', 2 => 'Pharmaceutical intermediates', 3 => '', ), 'term' => 'Intervalle variable', 'source_id' => 3744241, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Pharmaceutical intermediates', ), 'lastedit' => '20150722105901', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un renforçateur dépend de la première réponse après un intervalle de temps variable depuis la dernière opportunité pour un renforcement.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851727282176, 'nstext_full' => 'French (FR)', 's_attr' => (object) array( 'Definition' => 'A reinforcer is contingent on the first response after a variable interval of time since the last opportunity for reinforcement.', 'Domain' => 'Documentation', 'Industry' => 'Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Pharmaceutical intermediates', 'Usage Status' => 'New', 'Creation User' => 'lovinbnsingle', 'Creation Date' => '2012/9/5', 'Glossary' => 'MODULE_3_twgid1346807673617222', 'Term' => 'variable-interval', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'variable-interval_₁', )